Duska LR - Search Results

1

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: duska lr. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

2

Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.

Im DD, Duska LR, Rosenshein NB. Im DD, et al. Among authors: duska lr. Gynecol Oncol. 1995 Nov;59(2):179-82. doi: 10.1006/gyno.1995.0003. Gynecol Oncol. 1995. PMID: 7590468 Free article. Review.

3

Fallopian tube carcinoma.

Nikrui N, Duska LR. Nikrui N, et al. Among authors: duska lr. Surg Oncol Clin N Am. 1998 Apr;7(2):363-73. Surg Oncol Clin N Am. 1998. PMID: 9537982 Review.

4

Predictors of recurrence in surgical stage II endometrial adenocarcinoma.

Feltmate CM, Duska LR, Chang Y, Flynn CE, Nikrui N, Kiggundu E, Goodman A, Fuller AF, McIntyre JF. Feltmate CM, et al. Among authors: duska lr. Gynecol Oncol. 1999 Jun;73(3):407-11. doi: 10.1006/gyno.1999.5380. Gynecol Oncol. 1999. PMID: 10366468

5

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. Among authors: duska lr. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

6

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Cook S, et al. Gynecol Oncol. 2000 Apr;77(1):48-54. doi: 10.1006/gyno.1999.5710. Gynecol Oncol. 2000. PMID: 10739690

7

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.

Bristow RE, Duska LR, Montz FJ. Bristow RE, et al. Among authors: duska lr. Gynecol Oncol. 2001 Apr;81(1):92-9. doi: 10.1006/gyno.2000.6110. Gynecol Oncol. 2001. PMID: 11277657 Clinical Trial.

8

Endometrial cancer in women 40 years old or younger.

Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Duska LR, et al. Gynecol Oncol. 2001 Nov;83(2):388-93. doi: 10.1006/gyno.2001.6434. Gynecol Oncol. 2001. PMID: 11606102

9

Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.

Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL, Miller DS, Schorge JO. Lea JS, et al. Among authors: duska lr. Gynecol Oncol. 2002 Jan;84(1):115-9. doi: 10.1006/gyno.2001.6473. Gynecol Oncol. 2002. PMID: 11748986

10

Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.

Lea JS, Sheets EE, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: duska lr. Gynecol Oncol. 2002 Feb;84(2):285-8. doi: 10.1006/gyno.2001.6524. Gynecol Oncol. 2002. PMID: 11812088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters